Janus kinase (JAK) inhibitors have become promising treatments for atopic dermatitis (AD),
however no study directly comparing JAK inhibitors with each other has been reported. We …

Given the lack of head‐to‐head studies of systemic therapies in moderate‐to‐severe atopic
dermatitis (AD), network meta‐analyses (NMAs) can provide comparative efficacy and safety …

Background Atopic dermatitis is a common, chronically recurring inflammatory skin disease.
It gives rise to a high disease burden and is of major importance in social medicine. Methods …

Atopic dermatitis is the most prevalent chronic inflammatory skin condition globally. The
burden of atopic dermatitis on children and adults is extensive and there is also significant …

Background Additional long-term treatments are needed for moderate-to-severe atopic
dermatitis (AD). An ongoing, open-label, 5-year extension trial, ECZTEND (NCT03587805) …

Introduction Although previously regarded as a children's disease, it is clear that atopic
dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with …

Abstract Purpose of Review Atopic dermatitis (AD) and allergic asthma are complex
disorders with significant public health burden. This review provides an overview of the …

Background Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by
recurrent eczematous lesions and intense pruritus. AD patients are known to face a …

Biomarkers associated with the development of comorbidities in atopic dermatitis (AD)
patients have been reported, but have not yet been systematically reviewed. Seven …

Atopic dermatitis (AD) is a dermatological disorder that affects patients' mental health and
psychological state in complex ways. The importance of understanding the entire scope of …